Antipathogenic nanostructures
US-2024341310-A1 · Oct 17, 2024 · US
US10779539B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10779539-B2 |
| Application number | US-201715645838-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 10, 2017 |
| Priority date | May 19, 2015 |
| Publication date | Sep 22, 2020 |
| Grant date | Sep 22, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Antimicrobial cationic polycarbonates and polyurethanes have been prepared comprising one or more pendent guanidinium and/or isothiouronium groups. Additionally, antimicrobial particles were prepared having a silica core linked to surface groups comprising a guanidinium and/or isothiouronium group. The cationic polymers and cationic particles can be potent antimicrobial agents against Gram-negative microbes, Gram-positive microbes, and/or fungi.
Opening claim text (preview).
What is claimed is: 1. A method, comprising: conducting an organocatalyzed ring opening polymerization of a cyclic carbonate monomer using a particle comprising i) a core and ii) alcohol and/or amine surface groups covalently linked to the core, the surface groups capable of initiating the ring opening polymerization, thereby forming an initial polymer-modified particle, the cyclic carbonate monomer having a structure according to formula (M-1): wherein ring atoms of (M-1) are numbered 1 to 6, each B′ is an independent acid-labile protecting group, L′ is a divalent hydrocarbon radical comprising 2 to 30 carbons, each R′ is an independent monovalent radical selected from the group consisting of hydrogen and alkyl groups comprising 1 to 6 carbons, R″ is a monovalent radical selected from the group consisting of hydrogen and alkyl groups comprising 1 to 6 carbons, and Y′ is *—O—* or *—N(H)—*; and treating the initial polymer-modified particle with a protic acid, thereby forming a second polymer-modified particle comprising a cationic polymer chain covalently linked to one of the surface groups, the cationic polymer chain comprising a cationic subunit of formula (A-1): wherein atoms numbered 1, 2, 3, 4, 5, and 6 of (A-1) are backbone atoms of the cationic polymer, m is 1 or 2, n is 0 or 1, wherein when m is 2, n is 0, each R′ is an independent monovalent radical selected from the group consisting of hydrogen and alkyl groups comprising 1 to 6 carbons, R″ is a monovalent radical selected from the group consisting of hydrogen and alkyl groups comprising 1 to 6 carbons, and each Q″ is an independent group comprising a guanidinium group. 2. The method of claim 1 , wherein each R′ is hydrogen. 3. The method of claim 1 , wherein R″ is methyl or ethyl. 4. The method of claim 1 , wherein Y′ is *—O—*. 5. The method of claim 1 , wherein Y′ is *—N(H)—*. 6. The method of claim 1 , wherein the cationic polymer chain is a polycarbonate. 7. The method of claim 1 , wherein the second polymer-modified particle is capable of killing a Gram-positive bacterium, a Gram-negative bacterium, and/or a fungus. 8. The method of claim 1 , wherein m is 1 and n is 1. 9. The method of claim 1 , wherein (M-1) is wherein n is a positive integer having a value of 1 to 6. 10. The method of claim 1 , wherein (M-1) is wherein n is a positive integer having a value of 1 to 6. 11. The method of claim 1 , wherein (M-1) is 12. The method of claim 1 , wherein the cationic subunit has a structure according to formula (A-2): wherein atoms numbered 1, 2, 3, 4, 5, and 6 of (A-2) are backbone atoms of the cationic polymer, L′ is a divalent hydrocarbon radical comprising 2 to 30 carbons, Q′ is *—N(H)—*, each R′ is an independent monovalent radical selected from the group consisting of hydrogen and alkyl groups comprising 1 to 6 carbons, R″ is a monovalent radical selected from the group consisting of hydrogen and alkyl groups comprising 1 to 6 carbons, X′ is a negative-charged counterion, and Y′ is *—O—* or *—N(H)—*. 13. The method of claim 1 , wherein L′ is selected from the group consisting of 1,2-ethylene, 1,3-propylene, 1,4-butylene, 1,5-pentylene, 1,4-cyclohexylene, and 1,4-phenylene. 14. The method of claim 1 , wherein the core of the particle is silica. 15. The method of claim 1 , wherein the core of the particle is a silica gel. 16. The method of claim 1 , wherein the surface groups comprise amine groups. 17. The method of claim 1 , wherein the particle has a median size between 5 nm and 200 micrometers. 18. The method of claim 1 , wherein the cationic polymer chain is capable of forming a complex by non-covalent interactions with a biologically active material selected from the group consisting of drugs and genes.
and at least one isocyanate or isothiocyanate group linked to a secondary carbon atom of the cycloaliphatic ring, e.g. isophorone diisocyanate · CPC title
Guanidine; Derivatives thereof · CPC title
with compounds of group C08G18/32 or C08G18/3271 and/or polyamines of C08G18/38 · CPC title
containing urethane groups · CPC title
containing nitrogen · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.